Abstract
Epidemiological studies demonstrate a possible relationship between chronic ethanol drinking and thrombotic diseases, such as myocardial infarction and stroke. However, the precise mechanism for this association remains unclear. Sulfatides are endogenous glycosphingolipids composed of ceramide, galactose, and sulfate, known to have anti-thrombotic properties. Low (0.5 g/kg/day), middle (1.5 g/kg/day), and high (3.0 g/kg/day) doses of ethanol were administered for 21 days intraperitoneally to female wild-type mice, and serum/liver sulfatide levels were measured. No significant changes in cholesterol and triglycerides were seen in serum and liver by ethanol treatment. However, serum/liver sulfatide levels were significantly decreased by middle- and high-dose ethanol treatment, likely due to downregulation of hepatic cerebroside sulfotransferase (CST) levels. Marked decreases in the expression of catalase and superoxide dismutases and ensuing increases in lipid peroxides were also observed in the livers of mice with middle- and high-dose ethanol treatment, suggesting the association between the suppression of hepatic CST expression and enhancement of oxidative stress. Furthermore, serum levels of tissue factor, a typical pro-coagulant molecule, were significantly increased in the mice with middle- and high-dose ethanol treatment showing decreases in serum sulfatide levels. Collectively, these results demonstrate that chronic ethanol consumption reduces serum sulfatide levels by increasing oxidative stress and decreasing the expression of CST in the liver. These findings could provide a mechanism by which chronic ethanol drinking increases thrombotic events.
Similar content being viewed by others
Abbreviations
- ALD:
-
Alcoholic liver disease
- ALT:
-
Alanine aminotransferase
- ApoB:
-
Apolipoprotein B
- ARSA:
-
Arylsulfatase A
- AST:
-
Aspartate aminotransferase
- CAT:
-
Catalase
- CST:
-
Cerebroside sulfotransferase
- CVD:
-
Cardiovascular disease
- CYBB:
-
NADPH oxidase 2
- GALC:
-
Galactosylceramidase
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- GPX:
-
Glutathione peroxidase
- HDL-C:
-
High-density lipoprotein cholesterol
- LDL-C:
-
Low-density lipoprotein cholesterol
- FABP:
-
Fatty acid-binding protein
- HNE:
-
Hydroxynonenal
- LS:
-
Lysosulfatides
- MALDI-TOF MS:
-
Matrix-assisted laser desorption ionization–time-of-flight mass spectrometry
- MDA:
-
Malondialdehyde
- MTTP:
-
Microsomal triglyceride transfer protein
- NCF:
-
Neutrophil cytosolic factor
- PCR:
-
Polymerase chain reaction
- PPAR:
-
Peroxisome proliferator-activated receptor
- ROS:
-
Reactive oxygen species
- SCP2:
-
Sterol carrier protein 2
- SD:
-
Standard deviation
- SOD:
-
Superoxide dismutase
- TF:
-
Tissue factor
- TG:
-
Triglyceride
- UGT:
-
UDP-glucuronosyltransferase
References
Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV (1989) Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 264:10388–10395
Aoyama T, Ueno I, Kamijo T, Hashimoto T (1994) Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene-product, is a rate-limiting enzyme in long-chain fatty-acid beta-oxidation system—cDNA and deduced amino amino-acid-sequence and distinct specificities of the cDNA-expressed protein. J Biol Chem 269:19088–19094
Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, Rhead WJ, Uetake K, Tanaka K, Hashimoto T (1995) Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 95:2465–2473
Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273:5678–5684
Bertola A, Mathews S, Ki SH, Wang H, Gao B (2013) Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 8:627–637
Brinton EA (2012) Effects of ethanol intake on lipoproteins. Curr Atheroscler Rep 14:108–114
Carmiel-Haggai M, Cederbaum AI, Nieto N (2003) Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 125:1818–1833
Carr TP, Andresen CJ, Rudel LL (1993) Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26:39–42
Carson EJ, Pruett SB (1996) Development and characterization of a binge drinking model in mice for evaluation of immunological effects of ethanol. Alcohol Clin Exp Res 20:132–138
Cederholm A, Frostegård J (2007) Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann N Y Acad Sci 1108:96–103
Djoussé L, Gaziano JM (2008) Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep 10:117–120
Dohi Y, Ikura T, Hoshikawa Y, Katoh Y, Ota K, Nakanome A, Muto A, Omura S, Ohta T, Ito A, Yoshida M, Noda T, Igarashi K (2008) Bach1 inhibits oxidative stress-induced cellular senescence by impeding p53 function on chromatin. Nat Struct Mol Biol 15:1246–1254
Furuta S, Hayashi H, Hijikata M, Miyazawa S, Osumi T, Hashimoto T (1986) Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver catalase. Proc Natl Acad Sci USA 83:313–317
Gaziano JM, Gaziano TA, Glynn RJ, Sesso HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens CH, Buring JE (2000) Light-to-moderate alcohol consumption and mortality in the Physicians’ Health Study enrollment cohort. J Am Coll Cardiol 35:96–105
Guo R, Ren J (2010) Alcohol dehydrogenase accentuates ethanol-induced myocardial dysfunction and mitochondrial damage in mice: role of mitochondrial death pathway. PLoS One 5:e8757
Guo R, Scott GI, Ren J (2010) Involvement of AMPK in alcohol dehydrogenase accentuated myocardial dysfunction following acute ethanol challenge in mice. PLoS One 5:e11268
Hara A, Radin NS (1978) Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem 90:420–426
Hara A, Taketomi T (1987) Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins. J Biochem 102:83–92
Hara A, Taketomi T (1991) Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J Biochem 109:904–908
Hara A, Kutsukake Y, Uemura K, Taketomi T (1993) Anticoagulant activity of sulfatide and its anti-thrombotic effect in rabbit. J Biochem 113:781–785
Hara A, Uemura K, Taketomi T (1996) Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen. Glycoconj J 13:187–194
Hu R, Li G, Kamijo Y, Aoyama T, Nakajima T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A (2007) Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconj J 24:565–571
Ishizuka I (1997) Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 36:245–319
Kloner RA, Rezkalla SH (2007) To drink or not to drink? That is the question. Circulation 116:1306–1317
Kyogashima M (2004) The role of sulfatide in thrombogenesis and haemostasis. Arch Biochem Biophys 426:157–162
Lakshman R, Garige M, Gong M, Leckey L, Varatharajalu R, Zakhari S (2010) Is alcohol beneficial or harmful for cardioprotection? Genes Nutr 5:111–120
Li G, Hu R, Kamijo Y, Nakajima T, Aoyama T, Inoue T, Node K, Kannagi R, Kyogashima M, Hara A (2007) Establishment of a quantitative, qualitative and high throughput analysis of sulfatides from small amounts of sera by MALDI-TOF MS. Anal Biochem 362:1–7
Lin Y, Kikuchi S, Tamakoshi A, Wakai K, Kawamura T, Iso H, Ogimoto I, Yagyu K, Obata Y, Ishibashi T (2005) Alcohol consumption and mortality among middle-aged and elderly Japanese men and women. Ann Epidemiol 15:590–597
Ma H, Li J, Gao F, Ren J (2009) Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol. J Am Coll Cardiol 54:2187–2196
Malcolm RD, Alkana RL (1981) Temperature dependence of ethanol depression in mice. J Pharmacol Exp Ther 217:770–775
Matsubara T, Tanaka N, Patterson AD, Cho JY, Krausz KW, Gonzalez FJ (2011) Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology 53:1282–1293
Matsubara T, Tanaka N, Krausz KW, Manna SK, Kang DW, Anderson ER, Luecke H, Patterson AD, Shah YM, Gonzalez FJ (2012) Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab 16:634–644
Motohashi H, Yamamoto M (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549–557
Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T (2004) Peroxisome proliferator-activated receptor α protects against alcohol-induced liver damage. Hepatology 40:972–980
Okamoto A, Iwamoto Y, Maru Y (2006) Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol 26:1087–1097
Okiyama W, Tanaka N, Nakajima T, Tanaka E, Kiyosawa K, Gonzalez FJ, Aoyama T (2009) Polyenephosphatidylcholine prevents alcoholic liver disease in PPARα-null mice through attenuation of increases in oxidative stress. J Hepatol 50:1236–1246
Paunio M, Virtamo J, Gref CG, Heinonen OP (1996) Serum high density lipoprotein cholesterol, alcohol, and coronary mortality in male smokers. BMJ 312:1200–1203
Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J (1997) Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J Biol Chem 272:27307–27312
Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C (2005) Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoire. J Biol Chem 280:6028–6035
Sesso HD (2001) Alcohol and cardiovascular health: recent findings. Am J Cardiovasc Drugs 1:167–172
Sheng X, Nakajima T, Wang L, Zhang X, Kamijo Y, Takahashi K, Tanaka N, Sugiyama E, Kyogashima M, Aoyama T, Hara A (2012) Attenuation of kidney injuries maintains serum sulfatide levels dependent on hepatic synthetic ability: a possible involvement of oxidative stress. Tohoku J Exp Med 227:1–12
Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T (2008a) PPARα activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 118:683–694
Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T (2008b) Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor α in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Int J Cancer 122:124–131
Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T (2008c) Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 42:413–418
Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T (2010) Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol 80:1601–1612
Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ (2012) Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology 56:118–129
Tsuchiya M, Ji C, Kosyk O, Shymonyak S, Melnyk S, Kono H, Tryndyak V, Muskhelishvili L, Pogribny IP, Kaplowitz N, Rusyn I (2012) Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice. Hepatology 56:130–139
Vasiliou V, Ziegler TL, Bludeau P, Petersen DR, Gonzalez FJ, Deitrich RA (2006) CYP2E1 and catalase influence ethanol sensitivity in the central nervous system. Pharmacogenet Genomics 16:51–58
Vatsyayan R, Kothari H, Pendurthi UR, Rao LV (2013) 4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure. Arterioscler Thromb Vasc Biol 33:1601–1611
Walker JE, Odden AR, Jeyaseelan S, Zhang P, Bagby GJ, Nelson S, Happel KI (2009) Ethanol exposure impairs LPS-induced pulmonary LIX expression: alveolar epithelial cell dysfunction as a consequence of acute intoxication. Alcohol Clin Exp Res 33:357–365
Wang L, Kamijo Y, Matsumoto A, Nakajima T, Higuchi M, Kannagi R, Kyogashima M, Aoyama T, Hara A (2011) Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patient via processes correlated to oxidative stress and platelet count. Glycoconj J 28:125–135
Xiaowei Z, Nakajima T, Kamijo Y, Li G, Hu R, Kannagi R, Kyogashima M, Aoyama T, Hara A (2009) Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides. Biochem Biophys Res Commun 390:1382–1388
Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ (2003) A critical involvement of oxidative stress in acute alcohol-induced hepatic TNFα production. Am J Pathol 163:1137–1146
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kanbe, H., Kamijo, Y., Nakajima, T. et al. Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice. Arch Toxicol 88, 367–379 (2014). https://doi.org/10.1007/s00204-013-1132-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-013-1132-3